from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2549c/vapC20

LFCtreatmentdescriptionclass of inhibitor

0.014

Amikacinug/mL Amikacintranslation

0.817

Cap5-10ug/mL Capreomycintranslation

0.049

Rox10-50 ug/mL Roxithromycintranslation

0.325

SM2-5 ug/mL Streptomycintranslation

-0.176

Tet5-10 ug/mL Tetracyclinetranslation

-0.413

Rif0.2-5ug/mL Rifampicintranscription

-0.244

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.373

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.841

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.643

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.156

Clofazimine10-13 ug/mL Clofaziminerespiration

0.539

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.321

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.798

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.756

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.341

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.630

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.277

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.405

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.596

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.716

KCN5-20 ug/mL Potassium cyaniderespiration

-0.219

NaN30.2-2 mM Sodium aziderespiration

0.208

Nigericin50 uM Nigericinrespiration

0.311

TRC10-150 ug/mL Triclosanrespiration

-1.335

TRZ10-25 ug/mL Thioridazinerespiration

0.899

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.074

menadione6-10 ug/mL Menadionerespiration

-0.096

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.001

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.107

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.744

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.213

NRP_1Non-replicating persistence stage 1dosRassociated

0.247

Amp0.2mg/mL AmpicillincellWall

-0.221

Cephalexin20-100 ug/mL CephalexincellWall

0.328

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.093

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.113

EMB10-20 ug/mL EthambutolcellWall

0.379

Eta12-40 ug/mL EthionamidecellWall

0.429

INH0.2-0.4 ug/mL IsoniazidcellWall

0.267

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.995

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.153

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.359

BZA0.12 mg/mL BenzamidearomaticAmides

-0.038

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.357

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.204

H2O24 mM hydrogen peroxideDNAdamaging

0.452

Levo10 ug/mL LevofloxacinDNAdamaging

-0.601

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.846

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.659

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.171

UVUV-irradiationDNAdamaging

0.075

ARP41-4 ug/mL Antitubercular compound ARP4?

0.549

Antimycin12.5-50 ug/mL Antimycin A?

0.657

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.972

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.115

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.041

PA8240.2-2 ug/mL PA-824?

0.216

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.094

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.167

Verapamil50 uM Verapamil?

-0.189

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.091

methoxatin10-20 ug/mL Methoxatin?